The Max Foundation is proud to announce that our Chief Executive Officer Pat Garcia-Gonzalez has been named a finalist for the Union for International Cancer Control (UICC)’s CEO Award!
Pat is one of three finalists for this year’s award, alongside two friends and compatriots in the fight against cancer: Asem Mansour of King Hussein Cancer Center in Jordan, and Wondu Bekele Woldemariam of Mathiwos Wondu-YeEthiopia Cancer Society. Our thanks and congratulations go out to all three finalists for their tremendous impact and visionary leadership. The world is a better place for their contributions.
We would also like to thank the 18 different Patient Associations from around the world that sent letters in support of Pat’s nomination. You are the inspiration for all we do and we are so very grateful for your support.
The winner of the award will be announced on October 2nd at this year’s World Cancer Congress in Kuala Lumpur. Representatives from The Max Foundation and patient advocates from across Asia will be in attendance to share their knowledge, their experiences, and, of course, to cheer on Pat!
Visit the UICC website to learn more about the awards and the finalists.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
We have extended our partnership with BeOne Medicines and BeOne Care Foundation to provide access to treatment for chronic lymphocytic leukemia (CLL) in low- and middle-income countries, with the program projected to support approximately 1,000 patients cumulatively by the end of 2028. Read the full press release.
We’re excited to announce our collaboration with CancerWorld magazine! This special issue is about the 25th anniversary of an oral medication for chronic myeloid leukemia that transformed treatment, diagnostics, access, and patient advocacy. It features articles from the global community, including clinicians, researchers, patients, and advocates. Learn more about how a woman living with CML….
The Max Foundation is thrilled to welcome longtime advisor, Dr. Jerald Radich of the Fred Hutchinson Cancer Research Institute into the Executive Board. Dr. Radich has been a guiding star in our innovative work for many years helping people face cancer with dignity and hope, especially in the area of improving access to critical diagnostics in low- and middle-income countries.
